Cargando…

Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load

INTRODUCTION: There are concerns about pulmonary function tests (PFTs) being associated with aerosol generation and enhanced virus transmission. As a consequence, the number of PFTs was reduced significantly during the coronavirus disease 2019 pandemic. However, there are no robust data supporting t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomisa, G., Horváth, A., Farkas, Á., Nagy, A., Kis, E., Tamási, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414843/
https://www.ncbi.nlm.nih.gov/pubmed/34487775
http://dx.doi.org/10.1016/j.jhin.2021.08.025
_version_ 1783747859245432832
author Tomisa, G.
Horváth, A.
Farkas, Á.
Nagy, A.
Kis, E.
Tamási, L.
author_facet Tomisa, G.
Horváth, A.
Farkas, Á.
Nagy, A.
Kis, E.
Tamási, L.
author_sort Tomisa, G.
collection PubMed
description INTRODUCTION: There are concerns about pulmonary function tests (PFTs) being associated with aerosol generation and enhanced virus transmission. As a consequence, the number of PFTs was reduced significantly during the coronavirus disease 2019 pandemic. However, there are no robust data supporting this fear. OBJECTIVES: To perform real-life measurement of aerosol concentrations in a PFT laboratory to monitor the concentration of particles near the patient, and to model the associated potential viral load. METHODS: Two optical particle counters were used to sample the background concentration and the concentration of particles near the patient's mouth in a whole-body plethysmography box. Statistical evaluation of the measured particle concentration time series was completed. The particle exhalation rate was assessed based on the measured particle concentration data by applying the near-field/far-field theory. The number of exhaled viruses by an infected patient during the test was compared with the emission of viruses during quiet breathing and speaking. RESULTS: Twenty-five patients were included in the study. Eighteen patients showed a significant increase in aerosol concentration [mean 1910 (standard deviation 593) particles/L]. Submicron particles dominated the number size distribution of the generated particles, but large particles represented a higher volume fraction in the generated particles compared with background. An average gene exhalation rate of 0.2/min was estimated from this data. This is one order of magnitude higher than the release rate for the same infected person during quiet breathing, and of the same order of magnitude as the release rate during normal speaking. CONCLUSIONS: This study demonstrated that PFTs are aerosol-generating procedures. Based on these results, the moderate increase in viral load does not underpin stopping such examinations.
format Online
Article
Text
id pubmed-8414843
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
record_format MEDLINE/PubMed
spelling pubmed-84148432021-09-03 Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load Tomisa, G. Horváth, A. Farkas, Á. Nagy, A. Kis, E. Tamási, L. J Hosp Infect Article INTRODUCTION: There are concerns about pulmonary function tests (PFTs) being associated with aerosol generation and enhanced virus transmission. As a consequence, the number of PFTs was reduced significantly during the coronavirus disease 2019 pandemic. However, there are no robust data supporting this fear. OBJECTIVES: To perform real-life measurement of aerosol concentrations in a PFT laboratory to monitor the concentration of particles near the patient, and to model the associated potential viral load. METHODS: Two optical particle counters were used to sample the background concentration and the concentration of particles near the patient's mouth in a whole-body plethysmography box. Statistical evaluation of the measured particle concentration time series was completed. The particle exhalation rate was assessed based on the measured particle concentration data by applying the near-field/far-field theory. The number of exhaled viruses by an infected patient during the test was compared with the emission of viruses during quiet breathing and speaking. RESULTS: Twenty-five patients were included in the study. Eighteen patients showed a significant increase in aerosol concentration [mean 1910 (standard deviation 593) particles/L]. Submicron particles dominated the number size distribution of the generated particles, but large particles represented a higher volume fraction in the generated particles compared with background. An average gene exhalation rate of 0.2/min was estimated from this data. This is one order of magnitude higher than the release rate for the same infected person during quiet breathing, and of the same order of magnitude as the release rate during normal speaking. CONCLUSIONS: This study demonstrated that PFTs are aerosol-generating procedures. Based on these results, the moderate increase in viral load does not underpin stopping such examinations. The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2021-12 2021-09-03 /pmc/articles/PMC8414843/ /pubmed/34487775 http://dx.doi.org/10.1016/j.jhin.2021.08.025 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Tomisa, G.
Horváth, A.
Farkas, Á.
Nagy, A.
Kis, E.
Tamási, L.
Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load
title Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load
title_full Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load
title_fullStr Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load
title_full_unstemmed Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load
title_short Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load
title_sort real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the covid-19 pandemic and estimation of the associated viral load
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414843/
https://www.ncbi.nlm.nih.gov/pubmed/34487775
http://dx.doi.org/10.1016/j.jhin.2021.08.025
work_keys_str_mv AT tomisag reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload
AT horvatha reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload
AT farkasa reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload
AT nagya reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload
AT kise reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload
AT tamasil reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload